Diabetic Patients’ Views on Services Provided by Community Pharmacies

Abstract

Objectives The purpose of this study is to evaluate the attitude of the patients with diabetes towards and satisfaction with services provided by the community pharmacists in Tehran. Although there is no national guideline for diabetic disease management in Iran, pharmacists, as accessible and trained healthcare professionals, provide patients with consultation regarding medications, diet and physical activity. With the increasing number of patients with diabetes in Iran, it is needed to evaluate the patients’ satisfaction with and attitude towards pharmacists’ services to better understanding how such services can be improved. Methods This study is a cross‐sectional and self‐administrated survey conducted among patients with diabetes in Tehran between April and September 2016. Once finished with extracting the possible factors related to the attitudes of the patients with diabetes from existing literature, a standardised questionnaire with 35 questions was designed and distributed randomly among patients with diabetes. Four hundred and four completed questionnaires were finally returned. Key findings Although pharmacists’ services such as giving advices on diabetes management, giving information to patients and educating them about diabetes self‐management were found not to be implemented at an appropriate level, the majority of patients agreed that they receive consultation services from pharmacists regarding diabetes and had good attitude towards such services. More than 70% of patients agreed that, after receiving consultation services, their knowledge of diabetes increased and they have been more successful at diabetes self‐management. Conclusions According to the results, patients with diabetes in this study have relatively positive views on pharmacists and their services.

Type 2 Diabetes Patients’ Views of Local Pharmacists and Fulfilment with Pharmaceutical Diabetes Care in Syria’s Latakia Governorate: An Online Survey Research

“…Based on our previous systematic review [ 21 ] various pharmaceutical care approaches seem successful and effective in increasing patient adherence, controlling glucose levels, and improving diabetes understanding. Furthermore, numerous studies have demonstrated that the community pharmacist, as a health promoter, can play a critical role in diabetes prevention [ 34 , 36 , 37 , 38 , 41 , 47 , 48 , 49 ].…”

“…Several similar studies have assessed the diabetic satisfaction and expectations towards community-pharmacy services world-wide [ 14 , 15 , 22 , 23 , 24 , 28 , 29 , 35 , 38 , 40 , 45 , 50 , 51 ].…”

“…A comprehensive literature search was conducted before creating a self-administered questionnaire [ 21 , 23 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 ].…”

Managerial skills and performance in small businesses: the mediating role of organizational climate

“…The role of community pharmacies in Iran as a developing country might be different than other developed countries, such as North American or West European countries. For instance, over 85 per cent of community pharmacies in Iran are privately owned by individual pharmacists (Mehralian et al , 2018), whereas in the USA, over 80 per cent of pharmacies are owned by mega size corporations, such as CVS, Walgreens, Rite Aie and Walmart (S.K and A, 2017). This means that majority of pharmacies in the USA are not falling under the definition of small businesses.…”

Assessment the knowledge of community pharmacists in diabetic patients counseling in Ha’il, Saudi Arabia

“…Diabetes mellitus (DM) is one of the most prevalent chronic conditions and is associated with signi cant disability, morbidity, and mortality (1) worldwide; similar to Saudi Arabia's condition with 23.7% estimated prevalence among the adult population which is one of the highest percentages across the world (2). This metabolic disorder (DM) manifests in two main forms: type 1 and type 2 diabetes (3). It has a rapidly rising prevalence in both developed and developing countries with more than 422 million people thought to be suffering from the disease globally in 2014 (4).…”